Cooper/Haims Advisors, LLC Pfizer Inc Transaction History

Cooper/Haims Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $2,839 - $3,706	-68 Reduced 1.29%	5,185 $266,000
Q3 2022 Nov 01, 2022	SELL	$43.76 - $53.42 $2,450 - $2,991	-56 Reduced 1.05%	5,253 $230,000
Q2 2022 Jul 25, 2022	BUY	$46.53 - $55.17 $15,075 - $17,875	324 Added 6.5%	5,309 $278,000
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $66,703 - $82,654	1,458 Added 41.34%	4,985 $258,000
Q4 2021 Jan 21, 2022	SELL	$41.32 - $61.25 $156,396 - $231,831	-3,785 Reduced 51.76%	3,527 $208,000
Q1 2019 Apr 26, 2019	BUY	$37.5 - $41.2 $274,200 - $301,254	7,312 New	7,312 $311,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Cooper/Haims Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Cooper/Haims Advisors, LLC with notifications on news.